Bladder tumours: Time for a paradigm shift?

BJU International

Volumn 107, Issue 10, 2011, Pages 1543-1545

  Malmström, Per Uno ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

bladder cancer; classification; endpoints; systemic treatment

Indexed keywords

BCG VACCINE; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ADVANCED CANCER; BENIGN TUMOR; BLADDER CANCER; BLADDER TUMOR; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; LYMPHADENECTOMY; NARROW BAND IMAGING; NOTE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL APPROACH; SURVIVAL TIME; TREATMENT PLANNING;

DISEASE PROGRESSION; HUMANS; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 79955384057     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10235.x     Document Type: Note

References (19)

1. Whelan P,. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008; 99 (Suppl. 1): S90-2
2. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70 (Pubitemid 30046295)
3. Lazebnik Y,. What are the hallmarks of cancer? Nat Rev Cancer 2010; 10: 232-3
4. Prout GR, Marshall VF,. The prognosis with untreated bladder tumours. Cancer 1956; 9: 561-8
5. Malmström PU, Thörn M, Lindblad P, Bergström R, Adami HO,. Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960-1986. Eur J Cancer 1993; 29A: 1868-72 (Pubitemid 23288031)
6. Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR,. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol 2008; 42: 237-42 (Pubitemid 351574399)
7. Lindgren D, Frigyesi A, Gudjonsson S, et al,. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res 2010; 70: 3463-72
8. Brausi M, Collette L, Kurth K, et al,. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-31
9. van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC,. Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 2000; 9: 2973-80 (Pubitemid 32000770)
10. Holmäng S, Hedelin H, Anderström C, Holmberg E, Busch C, Johansson SL,. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162: 702-7 (Pubitemid 29436854)
11. Larsson P, Wijkström H, Thorstenson A, et al,. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 2003; 37: 195-201 (Pubitemid 36791815)
12. El-Abbady AA, Shoukry MS, Hanno AG, Younis LK, Abdel-Rahman M,. Repeated transurethral resection of recurrent superficial bladder tumors-does it affect the spread and stage of the tumor? Scand J Urol Nephrol 2002; 36: 60-4 (Pubitemid 34225304)
13. Nieder AM, Brausi M, Lamm D, et al,. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology 2005; 66 (Suppl. 1): 108-25 (Pubitemid 43049612)
14. de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S,. Survival after cystectomy for invasive bladder cancer. Eur J Surg Oncol 2010; 36: 292-7
15. Prout GR Jr, Griffin PP, Shipley WU,. Bladder carcinoma as a systemic disease. Cancer 1979; 43: 2532-9 (Pubitemid 9252406)
16. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 1999; 354: 533-40 [No authors listed]
17. Donat SM, Shabsigh A, Savage C, et al,. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol 2009; 55: 177-85
18. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ,. Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-49
19. Divrik RT, Yildirim U, Zorlu F, Ozen H,. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006; 175: 1641-4